Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Clinical Study of Raxibacumab Use in Sporadic Cases of Systemic Anthrax

NCT07478471 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT07478471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07478471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Clinical Study of Raxibacumab Use in Sporadic Cases of Systemic Anthrax
Lead sponsor
Emergent BioSolutions
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2027
Completion date
December 31, 2030
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infections, bacterial